ClinicalTrials.gov
public full text
Public Domain
Dual Treatment With Lithium and Valproate in ALS.
This is a pilot study in 40 subjects with definite ALS to evaluate the efficacy of valproate and lithium carbonate. After a random assignation of the dual treatment vs. placebo, a follow-up of 20 months will allow to know the clinical and functional evolution so as the status of biomarkers under each treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease#1164027
- Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis#1369435
- Minimum important slowing of disease progression as determined by the ALS functional rating scale – a survey of patient expectations toward disease-modifying drugs in ALS#215650
- A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients#876819
- Tolerability, Safety and Efficacy of Vortioxetine#1125453
Record · ID 1337546
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive